Gastrointestinal Tract
Aminosalicylate Therapy
Epidemiology
Rectal neuroendocrine tumor incidence ‘rapidly increasing’ in young adults, warrants study
CHICAGO — Incidence of rectal neuroendocrine tumors has increased in younger adults compared with older adults over the past 20 years, mostly driven by a rise in younger women, according to research presented at Digestive Disease Week.
Gut-based neurotoxin triggers inflammation associated with Alzheimer's disease
A neurotoxin derived from bacteria in the gastrointestinal tract has been identified as a major contributor to Alzheimer’s disease, researchers reported in Frontiers in Neurology.
Study exploring treatment in patients with CKD, gout completes cohorts A, B enrollment
Allena Pharmaceuticals Inc. announced its ALLN-346 Phase 2a Study 202 examining ALLN-346 treatment in patients with gout and advanced chronic kidney disease has completed enrollment for cohorts A and B.
Uncovering gastrointestinal involvement in systemic sclerosis requires 'asking the right questions'
Although rheumatologists are more attuned to the skin symptoms associated with systemic sclerosis, there should be a “heightened awareness” of gastrointestinal involvement, which is highly prevalent among this patient population and can precede skin manifestations, according to data presented at the virtual ACR State-of-the-Art Clinical Symposium.
In PCI population, cancer confers mortality, bleeding risks
Among patients who underwent PCI, those with cancer had elevated risks for cardiac mortality and bleeding, researchers reported in JACC: CardioOncology.